Literature DB >> 8724634

Treatment of relapse after allogeneic bone marrow transplantation.

S A Giralt1, K van Besien.   

Abstract

Mesh：

Year:  1996        PMID： 8724634     DOI： 10.1007/978-1-4613-1261-1_12

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  2 in total

1.  CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.

Authors:  Asad Bashey; Bridget Medina; Sue Corringham; Mildred Pasek; Ewa Carrier; Linda Vrooman; Israel Lowy; Scott R Solomon; Lawrence E Morris; H Kent Holland; James R Mason; Edwin P Alyea; Robert J Soiffer; Edward D Ball
Journal:  Blood       Date:  2008-10-30       Impact factor: 22.113

2.  Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies.

Authors:  Issa F Khouri; Irina Fernandez Curbelo; Francesco Turturro; Elias J Jabbour; Denái R Milton; Roland L Bassett; Luis M Vence; James P Allison; Alison M Gulbis; Padmanee Sharma
Journal:  Clin Cancer Res       Date:  2017-12-15       Impact factor: 12.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.